Boston Scientific, a major medical technology company, recently confirmed that it was the target of a cyberattack that disrupted its supply chain and shipping operations. The incident resulted in temporary delays for customers awaiting medical equipment, as the company was forced to take certain systems offline to contain the breach and secure its digital infrastructure.

While the company has not disclosed the specific nature of the attack—such as whether it involved ransomware or data theft—it stated that it is working with third-party cybersecurity experts and law enforcement to investigate the situation. The disruption caused immediate concern among investors, leading to a notable decline in the company’s stock price following the announcement.

There is currently no official confirmation regarding whether sensitive patient data was compromised, as the company’s primary focus remains on restoring its logistical capabilities. Boston Scientific has emphasized that it is prioritizing the continuity of care for healthcare providers who rely on its devices. The incident highlights the ongoing vulnerability of large-scale medical manufacturers to digital threats, which can have direct consequences on the availability of critical healthcare supplies. As the investigation continues, the company has pledged to provide updates as more information becomes available regarding the scope of the impact.